A Novel CXCR4 antagonist enhances angiogenesisviamodifying the ischaemic tissue environment

Author:

Yan Xiaoqing123,Dai Xiaozhen24,He Luqing1,Ling Xiao1,Shao Minglong1,Zhang Chi1,Wang Yuehui5,Xiao Jian1,Cai Lu123,Li Xiaokun1,Tan Yi123ORCID

Affiliation:

1. Chinese-American Research Institute for Diabetic Complications; Wenzhou Medical University; Chashan University-town; Wenzhou Zhejiang China

2. Pediatric Research Institute; Department of Pediatrics; University of Louisville; Louisville KY USA

3. Chinese-American Pediatric Research Institute at the First Hospital of Wenzhou Medical University; Wenzhou Zhejiang China

4. School of Biomedicine; Chengdu Medical College; Chengdu Sichuan China

5. Department of Geriatric Medicine; the first hospital of Jilin university; Changchun Jilin China

Funder

Natural Science Foundation of Zhejiang Province

Key Science and Technology Development Plan from Wenzhou City

Research Development Fund of Wenzhou Medical University

Junior Faculty Award from American Diabetes Association

National Natural Science Foundation of China

Key New Drug Development Grants

Changjiang Innovation Team Program

Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications (Wenzhou Medical University)

Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences

Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3